Land: Japan
Sprog: engelsk
Kilde: すりの適正使用協議会 RAD-AR Council, Japan
Selexipag
Nippon Shinyaku Co., Ltd.
Selexipag
pale reddish brown tablet, diameter: 7.1 mm, thickness: 3.4 mm
Print on wrapping: (face) ウプトラビ錠0.4mg 262 0.4
(back) Uptravi Tab.0.4mg ウプトラビ錠 0.4mg 0.4
Drug Information Sheet("Kusuri-no-Shiori") Internal Revised: 08/2021 The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment. BRAND NAME: UPTRAVI TABLETS 0.4MG ACTIVE INGREDIENT: Selexipag DOSAGE FORM: pale reddish brown tablet, diameter: 7.1 mm, thickness: 3.4 mm IMPRINT OR PRINT ON WRAPPING: (face) ウプトラビ錠 0.4mg 262 0.4 (back) Uptravi Tab.0.4mg ウプトラビ錠 0.4mg 0.4 EFFECTS OF THIS MEDICINE This medicine reduces blood pressure in the pulmonary artery and increases quantity of blood pumped into the pulmonary artery. It consequently improves shortness of breath and fatigue. It is usually used to treat pulmonary artery hypertension and chronic thromboembolic pulmonary hypertension. THE FOLLOWING PATIENTS MAY NEED TO BE CAREFUL WHEN USING THIS MEDICINE.BE SURE TO TELL YOUR DOCTOR AND PHARMACIST. ・If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines or foods. If you have liver disorder or pulmonary hypertension accompanied by pulmonary venous occlusive disease. ・If you are pregnant or breastfeeding. ・If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.) DOSING SCHEDULE (HOW TO TAKE THIS MEDICINE) ・ Your dosing schedule prescribed by your doctor is(( to be written by a healthcare professional )) ・In general, for adults, start taking 0.2 mg of the active ingredient at a time, twice a day after meals. Then the dose will be increased by 0.2 mg per dose in at least 7-day intervals, while checking the tolerabili Læs hele dokumentet